Josephine Chambers, APRN
Family · Michigan City, INNPI 1629614771
Payments from drug & device makers
Across 333 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Collegium Pharmaceutical, Inc.$393
- Almatica Pharma LLC$285
- Pfizer$251
- Scilex Pharmaceuticals Inc.$224
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,701100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $1,329 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 94 | $1,292 |
| Collegium Pharmaceutical, Inc. | 25 | $393 |
| Almatica Pharma LLC | 24 | $285 |
| Pfizer | 15 | $251 |
| Scilex Pharmaceuticals Inc. | 13 | $224 |
| Lundbeck LLC | 9 | $201 |
| Biodelivery Sciences International, Inc. | 14 | $187 |
| Lilly USA, LLC | 9 | $168 |
| Biohaven Pharmaceuticals, Inc. | 6 | $126 |
| Tersera Therapeutics LLC | 4 | $113 |
| Teva Pharmaceuticals USA, Inc. | 5 | $112 |
| GRT US Holding, Inc. | 6 | $104 |
| Boston Scientific | 3 | $103 |
| Amgen | 5 | $102 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $78 |
| Vertex | 4 | $73 |
| Averitas Pharma Inc. | 3 | $72 |
| IBSA Pharma Inc. | 5 | $67 |
| SPR Therapeutics, Inc | 2 | $58 |
| Hikma Pharmaceuticals USA | 3 | $49 |
| Radius Health, Inc. | 3 | $49 |
| Novartis | 2 | $46 |
| Nalu Medical, Inc. | 2 | $40 |
| Spinal Simplicity, LLC | 1 | $33 |
| Medtronic | 1 | $27 |
| Si-bone, Inc. | 2 | $26 |
| Nevro Corp. | 1 | $26 |
| Vertos Medical, Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Neuronetics, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$5,702 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 48 | $116,663 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,234 | $62,291 |
| BelbucaBuprenorphine Hcl | 46 | $41,813 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 951 | $36,894 |
| ZtlidoLidocaine | 19 | $27,081 |
| Lidocaine | 83 | $15,159 |
| Xtampza ErOxycodone Myristate | 13 | $12,294 |
| Nurtec OdtRimegepant Sulfate | 12 | $11,746 |
| Gabapentin | 584 | $9,288 |
| Pregabalin | 300 | $8,810 |
| Oxycodone Hcl | 221 | $7,527 |
| MovantikNaloxegol Oxalate | 15 | $6,929 |
| Buprenorphine | 16 | $5,417 |
| Naloxone Hcl | 82 | $4,633 |
| Gabapentin ErGabapentin | 13 | $4,498 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,292 | $116,66348 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $393 | $54,10759 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $224 | $27,08119 claims |
| PfizerNurtec Odt | $251 | $11,74612 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $49 | $5,87442 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.
Other family in Michigan City
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.